Study unveils maternal mortality tracking trends
March 20th 2024Delve into the implications of a study investigating maternal mortality tracking methods in the United States, as OB Hospitalist Group's Chief Medical Officer, Mark Simon, MD, highlights critical factors often overlooked and emphasizes collaborative care for preventing deaths.
Elinzanetant's efficacy for vasomotor symptoms confirmed in phase 3 trial
March 19th 2024Bayer's OASIS 3 trial affirmsed the safety and efficacy of elinzanetant in reducing moderate to severe vasomotor symptoms, bolstering confidence in its potential as a non-hormonal solution for menopause-related issues.
Gender disparity not found for alcohol use disorder’s link to suicide
March 18th 2024A recent study sheds light on the significant association between alcohol use disorder and suicide mortality found regardless of sex, emphasizing the importance of addressing alcohol use disorder in suicide prevention strategies.
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care
March 18th 2024Marlena S. Fejzo, PhD, sheds light on Harmonia Healthcare's innovative approach to tackling hyperemesis gravidarum, offering personalized care and telehealth options to address unmet patient needs and reduce emergency room visits.
Multicomponent intervention boosts quality of life in overactive bladder patients
March 15th 2024A recent study reveals the efficacy of a cognitive behavior therapy program, showcasing significant improvements in health-related quality of life among women grappling with moderate to severe overactive bladder.
NIH: Intervention mitigates postpartum depression and anxiety risks
March 15th 2024A recent study from the National Institutes of Health reveals an intervention led by non-specialist providers during pregnancy significantly lowers postpartum depression and anxiety risks, especially crucial for women in resource-poor settings where mental health care access is limited.
Optimizing pain management post urogynecologic surgery with restrictive opioid protocol
March 14th 2024A recent study suggests that restrictive opioid prescribing protocols post-urogynecologic surgery are as effective as standard protocols, emphasizing the importance of multimodal analgesia and outpatient follow-up for patient satisfaction.
Impact of serum estradiol decline before hCG-triggering on IVF outcomes
March 13th 2024A recent study delves into how serum estradiol decline preceding human chorionic gonadotropin administration affects in vitro fertilization outcomes, particularly among patients without oral contraceptive pretreatment, shedding light on the importance of monitoring during controlled ovarian hyperstimulation.
Dysmenorrhea management via telemedicine vs. in-person visits only
March 12th 2024Investigating dysmenorrhea outcomes with low-dose pill prescriptions reveals no significant difference between combination telemedicine and in-person consultations vs in-person only, prompting further exploration into telemedicine's role in gynecological care.
Study finds no increased stress urinary incontinence recurrence risk from childbirth
March 11th 2024A recent meta-analysis challenged common clinical assumptions, finding no increased risk of stress urinary incontinence recurrence or need for reoperation after subsequent pregnancy and childbirth following a midurethral sling procedure.
Lack of association found between vitamin D and miscarriage risk
March 8th 2024Investigating the relationship between 25-hydroxyvitamin D (25OHD) levels and miscarriage risk, a recent study utilizing mendelian randomization analysis found minimal causal association, suggesting no significant impact of vitamin D deficiency on miscarriage risk.
Fish and omega-3 supplement intake found lacking in pregnant women
March 8th 2024A recent study highlighted the disparity between dietary recommendations and actual intake of fish and omega-3 supplements among pregnant women, underscoring the need for targeted public health interventions to address this shortfall.
Surge of antidepressant use seen among female adolescents during COVID-19
March 7th 2024A study revealed a significant increase in antidepressant prescriptions among adolescents and young adults during the COVID-19 pandemic, particularly among female adolescents, indicating exacerbation of pre-existing mental health challenges.
NIH study finds long-acting ART safe for HIV suppression in adolescents
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that long-acting injectable antiretroviral therapy provides improved HIV suppression with minimal adverse effects, offering a promising alternative for adolescents and individuals struggling with daily oral regimens.
HIV remission among children reported over 1 year after treatment interruption
March 7th 2024Research presented at the 2024 Conference on Retroviruses and Opportunistic Infections reveals that 4 children, treated with antiretroviral therapy within 48 hours of birth, have achieved over a year of HIV remission.
Evaluating GeneXpert point-of-care testing for STIs
March 6th 2024A recent study assessed the effectiveness of GeneXpert point-of-care testing in detecting chlamydia, gonorrhoea, and trichomonas, revealing promising results but highlighting concerns over sensitivity rates, particularly for trichomonas.